Raymond James Financial
SRTAW

Raymond James Financial’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Raymond James Financial’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,300
Closed -$273 – 5180
2025
Q2 		$273 Buy
+1,300
New +$251 ﹤0.01% 6749

Other funds holding SRTAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial's SRTAW Position: Q3 2025 in Review

Raymond James Financial sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q3 2025, closing a stake of 1,300 shares — an estimated $273 sold.

Raymond James Financial first reported a position in SRTAW in Q2 2025 and held it in 1 quarter. The position peaked at $273 in Q2 2025. 6 funds tracked by Wall St. Rank hold SRTAW as of Q3 2025.

  • Raymond James Financial reported no remaining Strata Critical Medical Inc Warrants position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 1,300 Strata Critical Medical Inc Warrants shares in Q3 2025, an estimated $273.
  • Raymond James Financial first reported a position in Strata Critical Medical Inc Warrants in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Strata Critical Medical Inc Warrants position peaked at $273 in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.